Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Direct growth hormone replacement (recombinant HGH) delivers exogenous hormone that bypasses the pituitary gland entirely
This is generally used for lower doses and is slightly slower than IV or IM methods
A 30-year-old with no cancer history and no significant family history faces fundamentally different considerations than a 55-year-old with previous cancer or strong hereditary risk
ASL is funded by the National Institutes of Health grant 5T32DK007135-46
CJC-1295 Without DAC (Mod-GRF 1-29) pharmacological characterisation: Studies characterising the tetrasubstituted Mod-GRF 1-29 sequence established that the four amino acid substitutions produce a DPP-IV-resistant, endopeptidase-stable GHRH analogue with approximately 30-minute plasma half-life substantially extended versus native GHRH(1-29) without the albumin-binding continuous release profile of the DAC variant
L., Bannister L
US$ 29.70
US$ 28.37
US$ 28.17
US$ 27.13
US$ 23.98
US$ 23.20
US$ 22.90
US$ 29.73
US$ 21.65
US$ 20.88
US$ 26.67
US$ 24.20
US$ 27.63
US$ 24.20
US$ 20.88
US$ 20.93
